Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Treasury Shares (2024 - 2025)

Janux Therapeutics (JANX) has disclosed Treasury Shares for 2 consecutive years, with $704869.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 106.19% to $704869.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $704869.0 through Dec 2025, up 106.19% year-over-year, with the annual reading at $704869.0 for FY2025, 106.19% up from the prior year.
  • Treasury Shares for Q4 2025 was $704869.0 at Janux Therapeutics, up from $699467.0 in the prior quarter.
  • The five-year high for Treasury Shares was $704869.0 in Q4 2025, with the low at $17500.0 in Q2 2024.